Clinical research company IQVIA is to recruit 100 people at its East Point campus in Dublin. The roles relate to clinical project management, data management, drug safety, pharmacovigilance and biostatistics.
The company wants to fill the positions before the end of June 2019, and emphasises its requirement for pharmacovigilance specialists in a variety of safety services including both clinical trials and medicine safety.
Previously known as IMS Health and Quintiles, IQVIA has been established in Ireland since 1990. As well as supporting its global operations, IQVIA’s activities in Ireland include tracking the pharmaceutical market, conducting market research, providing consulting services across the healthcare spectrum, and offering contract resources to support healthcare companies commercialise their medicines.
Country director Martin Giblin said: “Today’s announcement represents a significant step in increasing our capability to serve our pharma customers across Europe and the world. Ireland has a rich base of life sciences talent, is a great place to do business and we look forward to continuing to grow our business here.”
IDA biopharmaceuticals head Tommy Fanning added: “We are delighted with today’s announcement, as it is a vote of confidence in Ireland and adds significantly to the expert cluster in biopharma and clinical research. IQVIA’s decision to build on its existing strong presence provides high quality challenging jobs which fit well with the future of the life sciences sector in Ireland."
In Association with
Photo: Finance minister Paschal Donohoe (centre) with Martin Giblin (left) and Tommy Fanning. (Pic: Robbie Reynolds)
